ArticleJournal of orthopaedic surgery and research2026
Multiomics combined drugs to explore the potential mechanism and treatment of ankylosing spondylitis.
Article in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ankylosing spondylitis (AS) is an immune-mediated disease with an unknown etiology, posing challenges in effective treatment. This study aims to investigate the underlying mechanisms and explore the potential of traditional Chinese medicine (TCM) as a treatment avenue. Employing a multiomics analysis and leveraging public databases, we scrutinized AS immune cell subpopulations and associated genes. Gene regulatory mechanisms were dissected, and molecular docking was performed to assess the therapeutic efficacy of TCM. Our findings revealed a significant elevation in effector CD8+ memory T (Tem) cells in AS. Notably, the expression of STAT4 in this cell subpopulation was observed to be down-regulated. This down-regulation might be influenced by multiple circRNAs and miR-574-5p. Intriguingly, components derived from guava leaves exhibited a stable binding affinity to STAT4. Immunohistochemistry and qPCR results confirmed low expression of STAT4 in paraspinal ligament muscle tissue. This comprehensive multiomics analysis sheds light on potential underlying mechanisms of AS and underscores the prospect of traditional Chinese medicine as a viable therapeutic option. The study provides valuable insights for future research endeavors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.